• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
ASO Author Reflections: The Role of Established Prognostic Factors in Long-Term Survival After Resection of Pancreatic Ductal Adenocarcinoma.ASO作者反思：既定预后因素在胰腺导管腺癌切除术后长期生存中的作用
Ann Surg Oncol. 2024 Sep;31(9):6199-6200. doi: 10.1245/s10434-024-15391-w. Epub 2024 May 20.
2
ASO Author Reflections: Importance of Preoperative Prediction of Survival in Resectable Pancreatic Ductal Adenocarcinoma.ASO作者反思：可切除性胰腺导管腺癌术前生存预测的重要性
Ann Surg Oncol. 2024 Oct;31(10):7074-7075. doi: 10.1245/s10434-024-15853-1. Epub 2024 Jul 17.
3
ASO Author Reflections: Very Early Recurrence After Curative Resection for Pancreatic Ductal Adenocarcinoma: The Challenge of Minimal Residual Disease.ASO作者反思：胰腺导管腺癌根治性切除术后的极早期复发——微小残留病的挑战
Ann Surg Oncol. 2024 Jun;31(6):4115-4116. doi: 10.1245/s10434-024-15175-2. Epub 2024 Mar 12.
4
Vascular resection for locally advanced pancreatic ductal adenocarcinoma: analysis of long-term outcomes from a single-centre series.血管切除治疗局部进展期胰导管腺癌：单中心系列长期结果分析。
World J Surg Oncol. 2021 Apr 18;19(1):126. doi: 10.1186/s12957-021-02238-x.
5
ASO Author Reflections: Isolated Margin Positivity in Localized Pancreatic Ductal Adenocarcinoma and Operative Margin Revision.ASO作者反思：局部胰腺导管腺癌的孤立切缘阳性与手术切缘修正
Ann Surg Oncol. 2024 Sep;31(9):6197-6198. doi: 10.1245/s10434-024-15658-2. Epub 2024 Jun 21.
6
Three-year and five-year outcomes of surgical resection for pancreatic ductal adenocarcinoma: Long-term experiences in one medical center.胰导管腺癌手术切除的 3 年和 5 年结果：一家医疗中心的长期经验。
Asian J Surg. 2018 Mar;41(2):115-123. doi: 10.1016/j.asjsur.2016.11.009. Epub 2016 Dec 20.
7
Postoperative serum CEA and CA125 levels are supplementary to perioperative CA19-9 levels in predicting operative outcomes of pancreatic ductal adenocarcinoma.术后血清癌胚抗原（CEA）和糖类抗原125（CA125）水平在预测胰腺导管腺癌手术结果方面对围手术期糖类抗原19-9（CA19-9）水平具有补充作用。
Surgery. 2017 Feb;161(2):373-384. doi: 10.1016/j.surg.2016.08.005. Epub 2016 Nov 9.
8
Treatment strategy of intraductal papillary-mucinous tumor of the pancreas.胰腺导管内乳头状黏液性肿瘤的治疗策略
J Gastroenterol. 2005 Jul;40(7):773-4. doi: 10.1007/s00535-005-1648-2.
9
A single center experience in resectable pancreatic ductal adenocarcinoma : the limitations of the surgery-first approach. Critical review of the literature and proposals for practice update.可切除胰腺导管腺癌的单中心经验：手术优先方法的局限性。文献综述及实践更新建议。
Acta Gastroenterol Belg. 2017 Oct-Dec;80(4):451-461.
10
[Pylorus-preserving pancreatic head resection: a new standard for tumors].保留幽门的胰头切除术：肿瘤的新标准
Chirurg. 2008 Dec;79(12):1107-14. doi: 10.1007/s00104-008-1571-1.

引用本文的文献

1
ASO Author Reflections: Intraductal Papillary Mucinous Neoplasm-Derived Pancreatic Cancer: A Need to Evaluate for Specific Staging Systems.ASO作者反思：导管内乳头状黏液性肿瘤衍生的胰腺癌：需要评估特定的分期系统。
Ann Surg Oncol. 2024 Dec;31(13):8758-8759. doi: 10.1245/s10434-024-16131-w. Epub 2024 Sep 10.

本文引用的文献

1
Cancer statistics, 2023.癌症统计数据，2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.

ASO Author Reflections: The Role of Established Prognostic Factors in Long-Term Survival After Resection of Pancreatic Ductal Adenocarcinoma.

作者信息

Mahmud Omar, Javed Ammar A, Fatimi Asad Saulat, Habib Alyssar, Grewal Mahip, He Jin, Wolfgang Christopher L, Besselink Marc G

机构信息

NYU Langone Health, NYU Grossman School of Medicine, New York City, NY, USA.

Medical College, Aga Khan University, Karachi, Pakistan.

出版信息

Ann Surg Oncol. 2024 Sep;31(9):6199-6200. doi: 10.1245/s10434-024-15391-w. Epub 2024 May 20.

DOI:10.1245/s10434-024-15391-w
PMID:38767804
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11300480/
Abstract
摘要